{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:15:23Z","timestamp":1791245723081,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.05.089","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:50:09Z","timestamp":1562867409000},"page":"5111-5120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Challenges with hepatitis B vaccination of high risk adults \u2013 A pilot program"],"prefix":"10.1016","volume":"37","author":[{"given":"Carolyn B.","family":"Bridges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tureka L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-0717","authenticated-orcid":false,"given":"Noele P.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Chavez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Fineis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boatemaa","family":"Ntiri-Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita K.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann K.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"RR-16","key":"10.1016\/j.vaccine.2019.05.089_b0005","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR-1","key":"10.1016\/j.vaccine.2019.05.089_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2019.05.089_b0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM197901183000301","article-title":"Viral hepatitis, type B\u2014studies on natural history and prevention reexamined","volume":"300","author":"Krugman","year":"1979","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.089_b0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2008-1040426","article-title":"Serologic diagnosis of acute and chronic viral hepatitis","volume":"11","author":"Hoofnagle","year":"1991","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.05.089_b0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/hep.28109","article-title":"Prevalence of chronic hepatitis B virus (HBV) infection in US households: National Health and Nutrition Examination Survey (NHANES), 1988\u20132012","volume":"63","author":"Roberts","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2019.05.089_b0030","unstructured":"CDC. Division of Viral Hepatitis. Viral hepatitis surveillance: United States, 201 https:\/\/www.cdc.gov\/hepatitis\/statistics\/2016surveillance\/pdfs\/2016HepSurveillanceRpt.pdf. Revised April 16, 2018 [accessed July 2, 2018]."},{"issue":"10","key":"10.1016\/j.vaccine.2019.05.089_b0035","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","article-title":"Hepatitis, B virus. The major etiology of hepatocellular carcinoma","volume":"61","author":"Beasley","year":"1988","journal-title":"Cancer"},{"issue":"5 Suppl","key":"10.1016\/j.vaccine.2019.05.089_b0040","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.089_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/7f73ed17-709e-4d7f-9aae-aab1f4a34985","article-title":"The increasing burden of imported chronic Hepatitis B\u2014United States, 1974\u20132008","volume":"8","author":"Mitchell","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.089_b0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl A","key":"10.1016\/j.vaccine.2019.05.089_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0163-4453(86)92668-X","article-title":"Overview of clinical studies with hepatitis B vaccine made by recombinant DNA","volume":"13","author":"Zajac","year":"1986","journal-title":"J Infect"},{"issue":"3A","key":"10.1016\/j.vaccine.2019.05.089_b0060","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/0002-9343(89)90525-1","article-title":"Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine","volume":"87","author":"Andre","year":"1989","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.05.089_b0065","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/21645515.2016.1164362","article-title":"Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus","volume":"12","author":"Van Der Meeren","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.089_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.05.089_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2019.05.089_b0080","unstructured":"Community Preventive Services Task Force. Vaccination. The Community Guide website. https:\/\/www.thecommunityguide.org\/topic\/vaccination [accessed July 2, 2018]."},{"key":"10.1016\/j.vaccine.2019.05.089_b0085","unstructured":"National Association of County and City Health Officials. Executive summary of the final report: formative evaluation of methods to improve the CDC Adult Hepatitis B Vaccination Initiative. http:\/\/archived.naccho.org\/."},{"key":"10.1016\/j.vaccine.2019.05.089_b0090","article-title":"Patient reminder and recall interventions to improve immunization rates","volume":"1","author":"Jacobson Vann","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.05.089_b0095","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.2105\/AJPH.2008.151332","article-title":"Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study","volume":"99","author":"Nelson","year":"2009","journal-title":"Am J Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2019.05.089_b0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.olq.0000258306.20287.a7","article-title":"Hepatitis B vaccination of men who have sex with men attendng an urban STD clinic: impact of an ongoing vaccination program, 1998\u20132003","volume":"34","author":"Gunn","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.089_b0105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2019.05.089_b0110","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.vaccine.2012.01.087","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2019.05.089_b0115","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1016\/j.vaccine.2013.05.067","article-title":"Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease","volume":"31","author":"Janssen","year":"2013","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2019.05.089_b0120","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1016\/j.vaccine.2015.05.070","article-title":"Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18\u201370 years of age","volume":"33","author":"Janssen","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.05.089_b0125","doi-asserted-by":"crossref","first-page":"D114","DOI":"10.1016\/j.vaccine.2015.09.054","article-title":"Meeting the challenges of immunizing adults","volume":"33","author":"Bridges","year":"2015","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.05.089_b0130","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1542\/peds.2009-1542H","article-title":"Cost of vaccine administration among pediatric practices","volume":"124","author":"Glazner","year":"2009","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:27Z","timestamp":1759401387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":26,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19307467"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges with hepatitis B vaccination of high risk adults \u2013 A pilot program","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}